Ignite Creation Date:
2024-05-05 @ 11:21 AM
Last Modification Date:
2025-12-17 @ 11:23 AM
Study NCT ID:
NCT00002161
Status:
None
Last Update Posted:
2005-06-24 00:00:00
First Post:
1999-11-02 00:00:00
Brief Title:
A Multi-Center, Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy and Safety of Adefovir Dipivoxil When Added to Standard Antiretroviral Therapy for the Treatment of HIV-Infected Patients With CD4 Cell Counts >= 200/mm3
Sponsor:
Gilead Sciences
Organization:
NIH AIDS Clinical Trials Information Service
Organization Data
Organization:
NIH AIDS Clinical Trials Information Service
Class:
INDUSTRY
Study ID:
232C
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Gilead Sciences
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
None
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None